COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint Inhibitors
Description
Cancer patients are a vulnerable population in the current coronavirus disease 2019 (COVID-19) outbreak. The impact of immune checkpoint inhibitors (ICIs) on the outcomes of COVID-19 infection in cancer patients remains largely unclear. We
